Related Experiment Video
Updated: Jan 26, 2026

Isolation of Mouse Pancreatic Endothelial Cells
Published on: June 21, 2024
ERK-containing microparticles from a diabetic mouse induce endothelial dysfunction.
Kumiko Taguchi1, Haruka Narimatsu1, Takayuki Matsumoto1
1Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, Shinagawa-ku, Tokyo, Japan.
Microparticles (MPs) from diabetic mice worsen endothelial dysfunction by activating ERK1/2 and reducing eNOS. These findings offer potential therapeutic targets for diabetic vascular complications.
Area of Science:
- Vascular Biology
- Endocrinology
- Cell Biology
Background:
- Endothelial dysfunction is a key feature of diabetic vascular complications.
- Microparticles (MPs) are vesicles released from cells, implicated in cell signaling and apoptosis.
- Circulating MPs from diabetic rats induce endothelial dysfunction, but mechanisms need clarification.
Purpose of the Study:
- To investigate how MPs from diabetic mice impact endothelial function.
- To elucidate the mechanisms by which diabetic MPs affect vascular health.
Main Methods:
- Collected MPs from streptozotocin-induced diabetic and control mice.
- Quantified and characterized MPs using flow cytometry, ELISA, and dot blotting.
- Incubated normal mouse aortas with MPs to analyze enzyme expression and vascular relaxation.
Main Results:
- Diabetic mice exhibited increased circulating MP levels.
- Diabetic MPs (DM MPs) impaired endothelial-dependent relaxation and adhered more readily to endothelial cells.
- DM MPs contained higher levels of extracellular signal-regulated kinase (ERK)1/2 and induced its activation.
- DM MPs reduced endothelial nitric oxide synthase (eNOS) in aortas, with eNOS detected in endothelial MPs.
Conclusions:
- Diabetic MPs significantly alter endothelial function primarily through ERK1/2 activation.
- ERK1/2 activation by DM MPs may represent a therapeutic target for diabetic vascular complications.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

